Investigating therapeutic intervention strategies
in pancreatic cancer

QR Code

Investigating therapeutic intervention strategies in pancreatic cancer

Based on the published literature and the identified gaps, this study aimed to investigate the therapeutic intervention strategies in pancreatic cancer. Preclinical validation of cannabinoids in a relevant mouse model of pancreatic cancer was performed, and the therapy-associated changes in the gut...

Full description

Bibliographic Details
Main Author:	Malhotra, Pratibha
Format:	Thesis
Published:	Curtin University 2023
Online Access:	http://hdl.handle.net/20.500.11937/93754

Similar Items

Therapeutic strategy for pancreatic carcinoma: An overview
by: Amjad, Nasser Muhammad
Published: (2017)

Epithelial-mesenchymal transition as a therapeutic target for overcoming chemoresistance in pancreatic cancer
by: Elaskalani, O., et al.
Published: (2017)

Investigation of Novel Biomarkers for Pancreatic Cancer
by: Emmanouilidi, Aikaterini
Published: (2019)

Investigation of polymer drug conjugates for pancreatic cancer
by: Anane-Adjei, Akosua Bema
Published: (2020)

Hypermutation In Pancreatic Cancer
by: Humphris, J., et al.
Published: (2017)

Prospective therapeutic strategies for cervical cancer
by: Mhd Zain, Nor Aini Lubis, et al.
Published: (2019)

Introduction of WT-TP53 into pancreatic cancer cells alters sensitivity to chemotherapeutic drugs, targeted therapeutics and nutraceuticals
by: Abrams, S., et al.
Published: (2018)

Preoperative drainage in pancreatic cancer
by: Kennedy, Eugene P, et al.
Published: (2010)

Diet and pancreatic cancer prevention
by: Casari, I., et al.
Published: (2015)

Expression of the Coxsackie and Adenovirus Receptor (CAR) in pancreatic cancer and normal pancreatic tissue
by: Verbeke, C. S., et al.
Published: (2006)

Targeting thioredoxin reductase in pancreatic cancer
by: Alhadyan, Khaled
Published: (2019)

Molecular and cellular mechanisms of chemoresistance in pancreatic cancer
by: Adamska, Aleksandra, et al.
Published: (2018)

Pancreatic cancer: Current research and future directions
by: Falasca, Marco, et al.
Published: (2016)

Association between family cancer history and risk of pancreatic cancer.
by: Schulte, A., et al.
Published: (2016)

Therapeutic interventions: an Islamic perspective
by: Rahman, Mohammad Tariqur, et al.
Published: (2008)

Rethinking therapeutic strategies in cancer: wars, fields, anomalies and monsters
by: Stewart, Simon, et al.
Published: (2016)

Therapeutic concentrations of antidepressants inhibit pancreatic beta-cell function via mitochondrial complex inhibition
by: Elmorsy, Ekramy, et al.
Published: (2017)

Development of Thermo-responsive materials for pancreatic cancer management
by: ElSherbeny, Amr Moustafa Said Moustafa
Published: (2024)

Genomic analyses identify molecular subtypes of pancreatic cancer
by: Bailey, P., et al.
Published: (2016)

Whole genomes redefine the mutational landscape of pancreatic cancer
by: Waddell, N., et al.
Published: (2015)

Mechanisms of oral bacterial virulence factors in pancreatic cancer
by: Sun, Zhong, et al.
Published: (2019)

Pharmacological modulation of apoptosis and autophagy in pancreatic cancer treatment
by: Stanslas, Johnson, et al.
Published: (2022)

Pancreatic cancer treatment with targeted therapies: are we there yet
by: Nwaefulu, O. Ngozi, et al.
Published: (2022)

Premalignant pancreatic cancer diagnosis using proteomic pattern analysis
by: Htike@Muhammad Yusof, Zaw Zaw
Published: (2015)

The role of G protein-coupled receptor 35 in pancreatic cancer
by: Kim, Minkyoung
Published: (2020)

Premalignant pancreatic cancer diagnosis using proteomic pattern analysis
by: Htike@Muhammad Yusof, Zaw Zaw
Published: (2014)

Emerging role of the KRAS-PDK1 axis in pancreatic cancer
by: Ferro, R., et al.
Published: (2014)

Returning individual research results for genome sequences of pancreatic cancer
by: Johns, A., et al.
Published: (2014)

Occupational exposure to N-nitrosamines and pesticides and risk of pancreatic cancer
by: Fritschi, Lin, et al.
Published: (2015)

Surgical Management in Patients With Pancreatic Cancer: a Queensland Perspective
by: Wylie, N., et al.
Published: (2013)

Therapeutic agent for treating cancer.
by: Abdullah, Norhafizah
Published: (2006)

Aptamer‑functionalized MOFs and AI‑driven strategies for early cancer diagnosis and therapeutics
by: Futane, Abhishek, et al.
Published: (2024)

Pancreatic injuries
by: Hassan, Radhiana
Published: (2018)

Mesoporous silica nanoparticles as anticancer drug carriers in pancreatic cancer treatment
by: Chung, Shei Li
Published: (2025)

Identification and molecular analysis of pancreatic cancer-derived small extracellular vesicles
by: Panda, Arunima
Published: (2024)

Key role of phosphoinositide 3-kinase class IB in pancreatic cancer
by: Edling, C., et al.
Published: (2010)

Generation of endogenous soluble PD-1 as a potential therapeutic strategy for cancer treatment
by: Wahid, Mussarat
Published: (2019)

Pancreatic cystosis: A rare pancreatic manifestation in cystic fibrosis
by: Mohammad A. Wazzan,
Published: (2015)

Therapeutic uses of epicatechin in diabetes and cancer
by: Abdulkhaleq, Layth Abdulmajeed, et al.
Published: (2017)

Pancreatic cancer-induced neutrophil extracellular traps: A potential contributor to cancer-associated thrombosis
by: Razak, N., et al.
Published: (2017)

Cannot write session to /tmp/vufind_sessions/sess_fl94fsfij1g1lenh2nj8c529ts